General

About Company
LuSeed has developed an intrasaccular flow diverter for treating cerebral aneurysms.

Industry

Sector :

Subsector :

Also Known As

LuSeed

founded date

01.01.2018

Number of employees

Company Type

For Profit

IPO status

Private

Description

LuSeed develops a solution for treating vasculature that enables the wall of a blood vessel to thicken up to full closure. LuSeed uses a patented electromagnetic wave emission tissue-enhancing technology for controlled vascular remodeling and strong tissue growth. Founded in 2017, the Luseed platform's initial application is made to treat cerebral aneurysms, while it may also be used to treat heart valves and aortic aneurysms.
Contacts

Phone number

Social url